Table 2. Chemotherapy regimens... | American Society of Hematology

Table 2.

Chemotherapy regimens administered to AYA with ALL, ages 15-39 y, 2004-2014, California

Setting	All years		2004-2007		2008-2011		2012-2014
Setting	N	%	N	%	N	%	N	%
Adult treatment
Adult ALL regimen	543	75.6	181	89.6	213	73.4	149	65.9
Hyper-CVAD	306	42.6	74	36.6	123	42.4	109	48.2
Adult cooperative group regimens*	125	17.4	61	30.1	40	13.7	24	10.6
Linker regimen	84	11.6	28	13.8	43	14.8	13	5.7
Other	28	3.8	18	8.9	7	2.4	<5	1.3
Pediatric ALL regimen	175	24.3	21	10.3	77	26.5	77	34.0
C10403	67	9.3	0	0	36	12.4	31	13.7
BFM	45	6.2	12	5.9	20	6.8	13	5.7
Pediatric cooperative group regimens	38	5.2	5	2.4	16	5.5	17	7.5
Other pediatric regimen	25	3.4	<5	1.9	5	1.7	16	7.0
Pediatric treatment
Pediatric ALL regimen	472	100.0	126	100.0	187	100.0	159	100.0
Pediatric cooperative group regimens^	328	69.4	79	62.6	123	65.7	126	79.2
Other pediatric regimen	144	30.5	47	37.3	64	34.2	33	20.7

Setting	All years		2004-2007		2008-2011		2012-2014
Setting	N	%	N	%	N	%	N	%
Adult treatment
Adult ALL regimen	543	75.6	181	89.6	213	73.4	149	65.9
Hyper-CVAD	306	42.6	74	36.6	123	42.4	109	48.2
Adult cooperative group regimens*	125	17.4	61	30.1	40	13.7	24	10.6
Linker regimen	84	11.6	28	13.8	43	14.8	13	5.7
Other	28	3.8	18	8.9	7	2.4	<5	1.3
Pediatric ALL regimen	175	24.3	21	10.3	77	26.5	77	34.0
C10403	67	9.3	0	0	36	12.4	31	13.7
BFM	45	6.2	12	5.9	20	6.8	13	5.7
Pediatric cooperative group regimens	38	5.2	5	2.4	16	5.5	17	7.5
Other pediatric regimen	25	3.4	<5	1.9	5	1.7	16	7.0
Pediatric treatment
Pediatric ALL regimen	472	100.0	126	100.0	187	100.0	159	100.0
Pediatric cooperative group regimens^	328	69.4	79	62.6	123	65.7	126	79.2
Other pediatric regimen	144	30.5	47	37.3	64	34.2	33	20.7

BFM, Berlin-Frankfurt-Münster; CVAD, cyclophosphamide, vincristine sulfate, Adriamycin, and dexamethasone.

Adult cooperative group regimens with the exception of C10403.